Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Direct contact dissolution therapy.

J L Thistle1

  • 1Mayo Medical Center, Rochester, MN 55905.

Bailliere'S Clinical Gastroenterology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Direct contact dissolution using methyl tert-butyl ether (MTBE) offers a safe and effective treatment for cholesterol gallstones. This method is ideal for patients who are high-risk surgical candidates or apprehensive about general anesthesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.

The American journal of gastroenterology·2000
Same author

Elevated liver enzymes preceding vessel involvement in Takayasu's arteritis.

Journal of hepatology·1999
Same author

Pathophysiology of bile duct stones.

World journal of surgery·1998
Same author

Current options for uncomplicated gallstones.

Contemporary internal medicine·1992
Same author

Safety of same-day sequential extracorporeal shock wave lithotripsy and dissolution of gallstones by methyl tert-butyl ether in dogs.

Mayo Clinic proceedings·1990
Same author

The incidence of cholelithiasis and cholecystitis in Rochester, Minn, 1950 through 1969.

Archives of internal medicine·1990
Same journal

Index.

Bailliere's clinical gastroenterology·2020
Same journal

Home enteral and parenteral nutrition in children.

Bailliere's clinical gastroenterology·1999
Same journal

Nutritional support in malnourished paediatric patients.

Bailliere's clinical gastroenterology·1999
Same journal

Cholestasis and end-stage liver disease.

Bailliere's clinical gastroenterology·1999
Same journal

Cystic fibrosis: nutritional consequences and management.

Bailliere's clinical gastroenterology·1999
Same journal

Pancreatic diseases (excluding cystic fibrosis).

Bailliere's clinical gastroenterology·1999
See all related articles

Area of Science:

  • Gastroenterology
  • Minimally Invasive Procedures

Background:

  • Gallstones pose a significant health concern, with traditional treatments like cholecystectomy carrying risks.
  • General anesthesia and surgery are not suitable for all patients, particularly those with high surgical risk or severe anxiety.
  • Alternative treatments are needed for patients who cannot undergo or refuse standard surgical interventions.

Purpose of the Study:

  • To evaluate the safety and efficacy of direct contact dissolution using MTBE for cholesterol gallstones.
  • To identify patient populations for whom MTBE dissolution is a suitable alternative treatment.

Main Methods:

  • Direct contact dissolution utilizing methyl tert-butyl ether (MTBE).
  • Procedure performed by experienced clinicians in specialized settings.

Related Experiment Videos

Main Results:

  • MTBE dissolution is a safe and effective treatment for cholesterol gallstones.
  • The procedure is well-tolerated by most patients.
  • It provides an alternative for patients at high risk for general anesthesia or surgery, and those refusing standard therapy.

Conclusions:

  • Direct contact dissolution with MTBE is a viable and effective treatment option for cholesterol gallstones.
  • It is particularly beneficial for high-risk surgical patients and those with significant apprehension towards conventional treatments.
  • Optimal outcomes are achieved when the procedure is performed by experienced teams at referral centers specializing in biliary tract stone disease.